Invesco’s Allergan plc AGN.PRA Stock Holding History

Invesco’s Portfolio AGN.PRA Stock Details AGN.PRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-49,300	Closed	-$28.9M	–	3827
2017 Q4	$28.9M	Sell	49,300 -2,200	-4%	-$1.42M	0.01%	1008
2017 Q3	$38M	Buy	51,500 +2,400	+5%	+$1.99M	0.01%	895
2017 Q2	$42.6M	Buy	49,100 +2,000	+4%	+$1.68M	0.01%	856
2017 Q1	$40M	Sell	47,100 -7,000	-13%	-$5.8M	0.01%	887
2016 Q4	$41.2M	Sell	54,100 -7,200	-12%	-$5.44M	0.01%	879
2016 Q3	$50.4M	Hold	61,300	–	–	0.02%	753
2016 Q2	$51.1M	Buy	61,300 +22,500	+58%	+$18.8M	0.02%	750
2016 Q1	$35.7M	Buy	38,800 +5,000	+15%	+$4.78M	0.01%	884
2015 Q4	$34.8M	Hold	33,800	–	–	0.01%	904
2015 Q3	$31.9M	Hold	33,800	–	–	0.01%	947
2015 Q2	$35.3M	Buy	+33,800	New	+$35.4M	0.01%	957

Other funds holding AGN.PRA

PWS

Peloton Wealth Strategists Indianapolis, Indiana $271M AUM 19.14% 1-Year Est. Return

Invesco's AGN.PRA Position: Q1 2018 in Review

Invesco sold out of Allergan plc (AGN.PRA) in Q1 2018, closing a stake of 49,300 shares — an estimated $28.9M sold.

Invesco first reported a position in AGN.PRA in Q2 2015 and held it in 11 quarters. The position peaked at $51.1M in Q2 2016. 1 fund tracked by Wall St. Rank holds AGN.PRA as of Q1 2018.

Invesco reported no remaining Allergan plc position as of Q1 2018 after selling out during the quarter.
Invesco sold 49,300 Allergan plc shares in Q1 2018, an estimated $28.9M.
Invesco first reported a position in Allergan plc in Q2 2015 and held it in 11 quarters.
Invesco's Allergan plc position peaked at $51.1M in Q2 2016.
1 fund tracked by Wall St. Rank held Allergan plc as of Q1 2018.

Based on Invesco's 13F filing for Q1 2018, filed 15 May 2018.